World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
14148
World Ranking
10769
National Ranking
4677

Keith A. Rodvold publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Keith A. Rodvold sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 229 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Keith A. Rodvold D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Keith A. Rodvold sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 62 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Keith A. Rodvold is affiliated with the University of Illinois at Chicago in the United States. Their research spans primarily the field of Medicine, with a specialized focus on Pharmacology, Epidemiology, and Infectious Diseases. Additional subfields include Molecular Medicine and Pediatrics, Perinatology and Child Health.

The scientist's work concentrates on several main topics, namely:

  • Antibiotics Pharmacokinetics and Efficacy
  • Pneumonia and Respiratory Infections
  • Antibiotic Resistance in Bacteria
  • Antimicrobial Resistance in Staphylococcus
  • Antifungal resistance and susceptibility
  • Nosocomial Infections in ICU
  • Urinary Tract Infections Management

Keith A. Rodvold has published extensively in various respected venues. Frequent publication outlets include:

  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • Antimicrobial Agents and Chemotherapy
  • Clinical Infectious Diseases
  • American Journal of Health-System Pharmacy
  • Journal of Antimicrobial Chemotherapy

Frequent collaborators in their research include:

  • Jennifer Lê
  • Michael J. Rybak
  • Ann Arbor
  • John Mi
  • Jim Gums

Recent papers authored or co-authored by Keith A. Rodvold reflect a focus on therapeutic monitoring and pharmacokinetics, particularly related to antibiotics for resistant infections and pneumonia. Select recent publications are:

  • "Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists," 2020, American Journal of Health-System Pharmacy
  • "Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists," 2020, Clinical Infectious Diseases
  • "Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists," 2020, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • "Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists," 2020, Journal of the Pediatric Infectious Diseases Society
  • "Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia," 2021, Journal of Antimicrobial Chemotherapy

Best Publications

  • Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

    Joseph S. Solomkin;John E. Mazuski;John S. Bradley;Keith A. Rodvold

  • Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

    Thomas P. Lodise;Nimish Patel;Ben M. Lomaestro;Keith A. Rodvold

  • Are Vancomycin Trough Concentrations Adequate for Optimal Dosing

    Michael N. Neely;Gilmer Youn;Brenda Jones;Roger W. Jelliffe;Roger W. Jelliffe

  • Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future

    Keith A. Rodvold;Kevin W. McConeghy

  • Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose

    Keith A. Rodvold;Mark H. Gotfried;Michael Cwik;Joan M. Korth-Bradley

  • Vancomycin: We Can't Get There From Here

    Nimish Patel;Manjunath P. Pai;Keith A. Rodvold;Ben Lomaestro

  • Vancomycin pharmacokinetics in patients with various degrees of renal function.

    K. A. Rodvold;R. A. Blum;J. H. Fischer;H. Z. Zokufa

  • Clinical pharmacokinetics of clarithromycin.

    Keith A. Rodvold

  • Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

    Keith A. Rodvold;Jomy M. George;Liz Yoo

  • Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers

    Keith A. Rodvold;Mark H. Gotfried;Mark H. Gotfried;Larry H. Danziger;Ronald J. Servi

  • Doxorubicin clearance in the obese.

    Keith A. Rodvold;D. A. Rushing;D. A. Tewksbury

  • Steady-State Plasma and Intrapulmonary Concentrations of Levofloxacin and Ciprofloxacin in Healthy Adult Subjects

    Mark H. Gotfried;Larry H. Danziger;Keith A. Rodvold

  • Clarithromycin and azithromycin: new macrolide antibiotics

    S. C. Piscitelli;Larry H. Danziger;Keith A. Rodvold

  • Antimicrobial Dosing in Obese Patients

    Rebecca Wurtz;Gail Itokazu;Keith Rodvold

  • Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation

    Thomas P. Lodise;Ben Lomaestro;Keith A. Rodvold;Larry H. Danziger

  • Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects

    Gurudatt Chandorkar;Jennifer A. Huntington;Mark H. Gotfried;Keith A. Rodvold

  • Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.

    David T. Bearden;Keith A. Rodvold

  • Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer

    Stephen C Piscitelli;Stephen C Piscitelli;Keith A Rodvold;Keith A Rodvold;Daniel A Rushing;Daniel A Rushing;Duane A Tewksbury;Duane A Tewksbury

  • A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria.

    Thomas G. Slama;Alpesh Amin;Stephen A. Brunton;Thomas M. File

  • Pharmacokinetics and Pharmacodynamics of Fluoroquinolones

    Keith A. Rodvold;Melinda Neuhauser

Frequent Co-Authors

John S. Bradley
John S. Bradley University of California, San Diego
Kevin W. Garey
Kevin W. Garey University of Houston
Thomas P. Lodise
Thomas P. Lodise Albany College of Pharmacy and Health Sciences
Michael J. Rybak
Michael J. Rybak Wayne State University
David P. Nicolau
David P. Nicolau Hartford Hospital
George L. Drusano
George L. Drusano University of Florida
John P. Quinn
John P. Quinn AstraZeneca (United Kingdom)
Joseph S. Solomkin
Joseph S. Solomkin University of Cincinnati Medical Center
Sujata M. Bhavnani
Sujata M. Bhavnani University at Buffalo, State University of New York
Sherwood L. Gorbach
Sherwood L. Gorbach Tufts University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens up a diverse range of online degrees and healthcare careers in the USA. Many students blend their science background with business skills by pursuing an mba healthcare management online. This pathway is ideal for those interested in leadership roles in hospitals, pharmaceutical companies, or research organizations.

Another popular route is medical coding and billing. These careers offer flexibility, high demand, and competitive salaries. If you're considering this path, it's important to compare certification options like ccs vs cpc, as each has different benefits, costs, and career prospects. For details on wages and advancement, check out current medical.coder salary data and requirements.

Unsure if this is the right path for you? Learn more about the pros and cons to determine is medical coding a good career for your goals. These related online degrees and certifications provide practical options for students with a passion for life sciences looking to make an impact in healthcare.

Best Scientists Citing Keith A. Rodvold

Trending Scientists

Recently Published Articles